IP Library Granted Patent US 10,350,111
Granted Patent B2
US 10,350,111 · App. 15/140,184 · Granted Jul 16, 2019

Systems and methods for cross-linking treatments of an eye

Inventors: Marc D. Friedman (Needham, MA); Pavel Kamaev (Lexington, MA); Mikhail Smirnov (North Andover, MA)
Assignee: Avedro, Inc.
A61F9/0079A61F9/007A61F9/008A61F9/00825A61F2009/00851A61F2009/00872A61F2009/00893
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,350,111
App. No.
15/140,184
Granted
Jul 16, 2019
Kind
B2
Abstract

A system for corneal treatment includes a light source that activates cross-linking in at least one selected region of a cornea treated with a cross-linking agent. The light source delivers photoactivating light to the at least one selected region of the cornea according to a set of parameters. The system includes a controller that receives input relating to the cross-linking agent and the set of parameters. The controller includes computer-readable storage media storing: (A) program instructions for determining cross-linking resulting from reactions involving ROS including at least peroxides, superoxides, and hydroxyl radicals, and (B) program instructions for determining cross-linking from reactions not involving oxygen. The controller executes the program instructions to output a calculated amount of cross-linking in the at least one selected region of the cornea. In response to the calculated amount of cross-linking, the light source adjusts at least one value in the set of parameters.

Claims (27)

1. A system for corneal treatment, comprising:

a light source configured to activate cross-linking in at least one selected region of a cornea treated with a cross-linking agent, the light source being configured to deliver photoactivating light to the at least one selected region of the cornea according to a set of parameters; and

a controller configured to receive input relating to the cross-linking agent and the set of parameters for the delivery of the photoactivating light, the controller including computer-readable storage media storing:

(A) a first set of program instructions for determining, from the input, cross-linking resulting from reactions involving reactive oxygen species (ROS) including at least peroxides, superoxides, and hydroxyl radicals, and

(B) a second set of program instructions for determining, from the input, cross-linking from reactions not involving oxygen,

the controller being configured to execute the first and second sets of program instructions to output, for the at least one selected region of the cornea, a calculation of at least one of corneal topography, corneal strength, corneal stiffness, corneal thickness, or a three-dimensional cross-link distribution,

wherein, in response to the calculation output by the controller, the light source is configured to adjust at least one value in the set of parameters for the delivery of the photoactivating light.

2. The system of claim 1 , further comprising an oxygen source and an oxygen delivery device configured to provide a concentration of oxygen from the oxygen source to the at least one selected region of the cornea,

wherein the input received by the controller further relates to the concentration of oxygen and the controller is configured to execute the first and second sets of program instructions to output the calculation based additionally on the concentration of oxygen.

3. The system of claim 1 , wherein the calculation indicates the three-dimensional distribution of cross-links in the at least one selected region of the cornea.

4. The system of claim 3 , wherein the controller is further configured to calculate a threshold depth corresponding to a healing response due to the three-dimensional distribution of cross-links and an effect of the reactive-oxygen species in the at least one selected region of the cornea.

5. The system of claim 3 , wherein the controller is further configured to calculate a biomechanical tissue stiffness threshold depth corresponding to a biomechanical tissue response due to the three-dimensional distribution of cross-links in the at least one selected region of the cornea.

6. The system of claim 3 , further comprising an oxygen source and a delivery device configured to provide a concentration of oxygen from the oxygen source to the at least one selected region of the cornea, wherein the concentration of the oxygen further determines the three-dimensional distribution of cross-links.

7. The system of claim 3 , wherein the input relating to the cross-linking agent indicates a specified concentration of the cross-linking agent and a soak time for the treatment of the cross-linking agent.

8. The system of claim 3 , wherein the first set of program instructions further determines cross-linking resulting from reactions involving reactive oxygen species (ROS) including singlet oxygen.

9. The system of claim 1 , wherein the input relating to the cross-linking agent indicates a specified concentration of the cross-linking agent and a soak time for the treatment of the cross-linking agent.

10. The system of claim 1 , wherein the first set of program instructions further determines cross-linking resulting from reactions involving reactive oxygen species (ROS) including singlet oxygen.

11. A system for corneal treatment, comprising:

a light source configured to activate cross-linking in at least one selected region of a cornea treated with a cross-linking agent, the light source being configured to deliver photoactivating light to the at least one selected region of the cornea according to a set of parameters;

an oxygen source and an oxygen delivery device configured to provide a concentration of oxygen from the oxygen source to the at least one selected region of the cornea; and

a controller configured to receive input relating to the cross-linking agent, the set of parameters for the delivery of the photoactivating light, and the concentration of oxygen, the controller including computer-readable storage media storing:

(A) a first set of program instructions for determining, from the input, cross-linking resulting from reactions involving reactive oxygen species (ROS) including at least peroxides, superoxides, and hydroxyl radicals, and

(B) a second set of program instructions for determining, from the input, cross-linking from reactions not involving oxygen,

the controller being configured to execute the first and second sets of program instructions to output, for the at least one selected region of the cornea, a calculation indicating a three-dimensional distribution of cross-links,

wherein, in response to the calculation output by the controller, at least one of: (i) the light source is configured to adjust at least one value in the set of parameters for the delivery of the photoactivating light, or (ii) the oxygen delivery device is configured to adjust a value of the concentration of oxygen delivered to the at least one selected region of the cornea.

12. The system of claim 11 , wherein the controller is further configured to calculate a threshold depth corresponding to a healing response due to the three-dimensional distribution of cross-links and an effect of the reactive-oxygen species in the at least one selected region of the cornea.

13. The system of claim 11 , wherein the controller is further configured to calculate a biomechanical tissue stiffness threshold depth corresponding to a biomechanical tissue response due to the three-dimensional distribution of cross-links in the at least one selected region of the cornea.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Nov 21, 2019
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: AVEDRO, INC.
Reel/Frame 051080/0756 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL NO. 14/140,184 PREVIOUSLY RECORDED AT REEL: 042167 FRAME: 0671. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 1, 2017
From: AVEDRO, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042390/0659 →
SECURITY INTEREST Recorded Apr 27, 2017
From: AVEDRO, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 042167/0671 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2016
From: SMIRNOV, MIKHAIL
To: AVEDRO, INC.
Reel/Frame 039917/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2016
From: FRIEDMAN, MARC D.
To: AVEDRO, INC.
Reel/Frame 039917/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2016
From: KAMAEV, PAVEL
To: AVEDRO, INC.
Reel/Frame 039915/0074 →
Continuity (3)
Continuation In Part PCTUS2015057628 · Oct 27, 2015
Provisional Application 62069094 · Oct 27, 2014
Related Publication 20160310319A1 · Oct 27, 2016
Cited By (2)
US 12,427,062 US 12,453,713